Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Disparities in HPV Vaccination Programs Worldwide

Disparities in HPV Vaccination Programs Worldwide News & Analysis Global Health Upsurge in Cases of Cutaneous Disparities in HPV Vaccination Leishmaniasis in Syria Programs Worldwide Vaccination for human papillomavirus (HPV) The Syrian conflict has created conditions varies according to the income level of coun- conducive to the outbreak of cutaneous tries, with HPV immunization programs in leishmaniasis (CL) in Syria and surrounding low- and middle-income countries being areas in the Middle East and North Africa, practically nonexistent, despite the fact that according to an editorial authored by most new cervical cancer cases and deaths experts from the United Kingdom and occur in these countries, report research- United States who reviewed literature on ers from Spain and France (Bruni L et al. Lan- the emergence of neglected tropical dis- cet Glob Health. 2016;4[7]:e453-e463). eases such as CL in these conflict regions Human papillomavirus vaccines were li- (Du R et al. PLoS Negl Trop Dis. 2016;10[5]: censed in 2006, and since that time have e0004545). been introduced in many countries, mainly Cutaneous lieshmaniasis is caused pri- for girls between the ages of 10 and 14 years. marily by Leishmania major or Leishmania To identify publicly funded HPV immuniza- tropica, parasites that cause disfiguring skin Recent studies report http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Disparities in HPV Vaccination Programs Worldwide

JAMA , Volume 316 (7) – Aug 16, 2016

Disparities in HPV Vaccination Programs Worldwide

Abstract

News & Analysis Global Health Upsurge in Cases of Cutaneous Disparities in HPV Vaccination Leishmaniasis in Syria Programs Worldwide Vaccination for human papillomavirus (HPV) The Syrian conflict has created conditions varies according to the income level of coun- conducive to the outbreak of cutaneous tries, with HPV immunization programs in leishmaniasis (CL) in Syria and surrounding low- and middle-income countries being areas in the Middle East and North Africa, practically...
Loading next page...
 
/lp/american-medical-association/disparities-in-hpv-vaccination-programs-worldwide-W2sxInewA6

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2016.10893
Publisher site
See Article on Publisher Site

Abstract

News & Analysis Global Health Upsurge in Cases of Cutaneous Disparities in HPV Vaccination Leishmaniasis in Syria Programs Worldwide Vaccination for human papillomavirus (HPV) The Syrian conflict has created conditions varies according to the income level of coun- conducive to the outbreak of cutaneous tries, with HPV immunization programs in leishmaniasis (CL) in Syria and surrounding low- and middle-income countries being areas in the Middle East and North Africa, practically nonexistent, despite the fact that according to an editorial authored by most new cervical cancer cases and deaths experts from the United Kingdom and occur in these countries, report research- United States who reviewed literature on ers from Spain and France (Bruni L et al. Lan- the emergence of neglected tropical dis- cet Glob Health. 2016;4[7]:e453-e463). eases such as CL in these conflict regions Human papillomavirus vaccines were li- (Du R et al. PLoS Negl Trop Dis. 2016;10[5]: censed in 2006, and since that time have e0004545). been introduced in many countries, mainly Cutaneous lieshmaniasis is caused pri- for girls between the ages of 10 and 14 years. marily by Leishmania major or Leishmania To identify publicly funded HPV immuniza- tropica, parasites that cause disfiguring skin Recent studies report

Journal

JAMAAmerican Medical Association

Published: Aug 16, 2016

There are no references for this article.